ShockWave Medical stock is trading -17.79% below its average target price of $284.89 after marking a 5.2% during today's evening session. Analysts are giving the mid-cap Medical Instruments & Supplies company an average rating of buy and target prices ranging from $165.0 to $330.0 per share.
The stock has an average amount of shares sold short at 3.9%, and a short ratio of 1.94. Since 1.18% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 93.3% of ShockWave Medical's shares being owned by this investor type.
Institutions Invested in ShockWave Medical
|2023-06-30||Vanguard Group Inc||10%||3,603,014||$843,897,943|
|2023-06-30||Wellington Management Group, LLP||4%||1,352,723||$316,834,782|
|2023-06-30||Artisan Partners Limited Partnership||3%||1,147,784||$268,833,969|
|2023-06-30||Price (T.Rowe) Associates Inc||3%||1,091,050||$255,545,732|
|2023-06-30||State Street Corporation||3%||1,018,186||$238,479,526|
|2023-06-30||JP Morgan Chase & Company||2%||835,138||$195,606,023|
|2023-06-30||Capital World Investors||2%||585,000||$137,018,700|
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on ShockWave Medical.